-
16928-10A selective inhibitor of human collagenase-3, also known as MMP-13, producing 89% inhibition at 10 µg/ml used to evaluate the role of MMP-13 in diverse processes.
-
16928-25A selective inhibitor of human collagenase-3, also known as MMP-13, producing 89% inhibition at 10 µg/ml used to evaluate the role of MMP-13 in diverse processes.
-
16928-5A selective inhibitor of human collagenase-3, also known as MMP-13, producing 89% inhibition at 10 µg/ml used to evaluate the role of MMP-13 in diverse processes.
-
16928-50A selective inhibitor of human collagenase-3, also known as MMP-13, producing 89% inhibition at 10 µg/ml used to evaluate the role of MMP-13 in diverse processes.
-
10599-1An inhibitor of PAD4 deimination activity (IC50 = 5.9 &muM) that also inhibits PAD1 and PAD3 (IC50 = 0.
-
10599-10An inhibitor of PAD4 deimination activity (IC50 = 5.9 &muM) that also inhibits PAD1 and PAD3 (IC50 = 0.
-
10599-5An inhibitor of PAD4 deimination activity (IC50 = 5.9 &muM) that also inhibits PAD1 and PAD3 (IC50 = 0.
-
12085-10An adenosine analog which shows selective cytotoxicity against both proliferating and non-dividing lymphocytes inhibits lymphocyte growth with an IC<sub>50</sub> value of 45 nM.
-
12085-100An adenosine analog which shows selective cytotoxicity against both proliferating and non-dividing lymphocytes inhibits lymphocyte growth with an IC<sub>50</sub> value of 45 nM.
-
12085-50An adenosine analog which shows selective cytotoxicity against both proliferating and non-dividing lymphocytes inhibits lymphocyte growth with an IC<sub>50</sub> value of 45 nM.
-
19455-1A macrolide antibiotic with effectiveness against pneumococci, Streptococcus, Listeria, Corynebacterium, and Helicobacter.
-
19455-5A macrolide antibiotic with effectiveness against pneumococci, Streptococcus, Listeria, Corynebacterium, and Helicobacter.